Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gastrointestinal Stromal Tumor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gastrointestinal Stromal Tumormarket, defines the market attractiveness level of Gastrointestinal Stromal Tumor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gastrointestinal Stromal Tumor industry, describes the types of Gastrointestinal Stromal Tumor market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastrointestinal Stromal Tumor market and the development prospects and opportunities of Gastrointestinal Stromal Tumor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastrointestinal Stromal Tumor market in Chapter 13.
By Player:
Bayer Aktiengesellschaft
Novartis
Pfizer
NATCO Pharma
Sun Pharmaceutical
By Type:
Stomach
Small Intestine
Others
By End-User:
Hospitals
Clinics
Specialized Cancer Treatment Centers
Other End Users
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gastrointestinal Stromal Tumor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gastrointestinal Stromal Tumor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gastrointestinal Stromal Tumor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gastrointestinal Stromal Tumor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gastrointestinal Stromal Tumor Market Analysis and Outlook to 2022
-
7.1 Global Gastrointestinal Stromal Tumor Consumption (2017-2022)
-
7.2 United States Gastrointestinal Stromal Tumor Consumption (2017-2022)
-
7.3 Europe Gastrointestinal Stromal Tumor Consumption (2017-2022)
-
7.4 China Gastrointestinal Stromal Tumor Consumption (2017-2022)
-
7.5 Japan Gastrointestinal Stromal Tumor Consumption (2017-2022)
-
7.6 India Gastrointestinal Stromal Tumor Consumption (2017-2022)
-
7.7 South Korea Gastrointestinal Stromal Tumor Consumption (2017-2022)
8 Region and Country-wise Gastrointestinal Stromal Tumor Market Analysis and Outlook to 2028
-
8.1 Global Gastrointestinal Stromal Tumor Consumption Forecast (2022-2028)
-
8.2 United States Gastrointestinal Stromal Tumor Consumption Forecast (2022-2028)
-
8.3 Europe Gastrointestinal Stromal Tumor Consumption Forecast (2022-2028)
-
8.4 China Gastrointestinal Stromal Tumor Consumption Forecast (2022-2028)
-
8.5 Japan Gastrointestinal Stromal Tumor Consumption Forecast (2022-2028)
-
8.6 India Gastrointestinal Stromal Tumor Consumption Forecast (2022-2028)
-
8.7 South Korea Gastrointestinal Stromal Tumor Consumption Forecast (2022-2028)
9 Global Gastrointestinal Stromal Tumor Market Outlook by Types and Applications to 2022
-
9.1 Global Gastrointestinal Stromal Tumor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Stomach Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Small Intestine Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastrointestinal Stromal Tumor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Specialized Cancer Treatment Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other End Users Consumption and Growth Rate (2017-2022)
10 Global Gastrointestinal Stromal Tumor Market Outlook by Types and Applications to 2028
-
10.1 Global Gastrointestinal Stromal Tumor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Stomach Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Small Intestine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gastrointestinal Stromal Tumor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Specialized Cancer Treatment Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other End Users Consumption Forecast and Growth Rate (2022-2028)
11 Global Gastrointestinal Stromal Tumor Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gastrointestinal Stromal Tumor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gastrointestinal Stromal Tumor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gastrointestinal Stromal Tumor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gastrointestinal Stromal Tumor Market Competitive Analysis
-
14.1 Bayer Aktiengesellschaft
-
14.1.1 Bayer Aktiengesellschaft Company Details
-
14.1.2 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Gastrointestinal Stromal Tumor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Gastrointestinal Stromal Tumor Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Gastrointestinal Stromal Tumor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Gastrointestinal Stromal Tumor Product and Service
-
14.4 NATCO Pharma
-
14.4.1 NATCO Pharma Company Details
-
14.4.2 NATCO Pharma Gastrointestinal Stromal Tumor Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 NATCO Pharma Gastrointestinal Stromal Tumor Product and Service
-
14.5 Sun Pharmaceutical
-
14.5.1 Sun Pharmaceutical Company Details
-
14.5.2 Sun Pharmaceutical Gastrointestinal Stromal Tumor Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sun Pharmaceutical Gastrointestinal Stromal Tumor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gastrointestinal Stromal Tumor
-
Figure Gastrointestinal Stromal Tumor Picture
-
Table Global Gastrointestinal Stromal Tumor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastrointestinal Stromal Tumor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastrointestinal Stromal Tumor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gastrointestinal Stromal Tumor Consumption by Country (2017-2022)
-
Figure United States Gastrointestinal Stromal Tumor Consumption and Growth Rate (2017-2022)
-
Table Europe Gastrointestinal Stromal Tumor Consumption and Growth Rate (2017-2022)
-
Figure China Gastrointestinal Stromal Tumor Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastrointestinal Stromal Tumor Consumption and Growth Rate (2017-2022)
-
Figure India Gastrointestinal Stromal Tumor Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastrointestinal Stromal Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Stromal Tumor Consumption Forecast by Country (2022-2028)
-
Figure United States Gastrointestinal Stromal Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastrointestinal Stromal Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gastrointestinal Stromal Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastrointestinal Stromal Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastrointestinal Stromal Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastrointestinal Stromal Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stomach Consumption and Growth Rate (2017-2022)
-
Figure Global Small Intestine Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Specialized Cancer Treatment Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Other End Users Consumption and Growth Rate (2017-2022)
-
Figure Global Stomach Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Small Intestine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialized Cancer Treatment Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other End Users Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gastrointestinal Stromal Tumor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gastrointestinal Stromal Tumor Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer Aktiengesellschaft (Foundation Year, Company Profile and etc.)
-
Table Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Aktiengesellschaft Gastrointestinal Stromal Tumor Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Gastrointestinal Stromal Tumor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Gastrointestinal Stromal Tumor Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Gastrointestinal Stromal Tumor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Gastrointestinal Stromal Tumor Product and Service
-
Table NATCO Pharma (Foundation Year, Company Profile and etc.)
-
Table NATCO Pharma Gastrointestinal Stromal Tumor Sales, Price, Value and Gross Profit (2017-2022)
-
Table NATCO Pharma Gastrointestinal Stromal Tumor Product and Service
-
Table Sun Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Sun Pharmaceutical Gastrointestinal Stromal Tumor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Gastrointestinal Stromal Tumor Product and Service
-
